<html><body><h2>Case: 1911927</h2><h3> CDS Time: 1969-10-02</h3>
<patient name=1911927>
69.0 year old White_Non-Hispanic Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">69</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">10</td><td width="200">1967-12-13</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">116</td><td width="200">1967-12-13</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">2</td><td width="200">1967-7-2</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">173</td><td width="200">1967-7-3</td></tr>
<tr><td width="200">Chloride</td><td width="200">100.0</td><td width="200">1967-12-13</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">33</td><td width="200">1967-7-3</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">90</td><td width="200">1969-10-2</td></tr>
<tr><td width="200">BNP</td><td width="200">962</td><td width="200">1967-12-13</td></tr>
<tr><td width="200">Weight</td><td width="200">176</td><td width="200">1969-10-2</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">143</td><td width="200">1967-7-3</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">223</td><td width="200">1967-7-3</td></tr>
<tr><td width="200">SGOT</td><td width="200">24</td><td width="200">1967-12-13</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">124</td><td width="200">1969-10-2</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">1</td><td width="200">1967-12-13</td></tr>
<tr><td width="200">Height</td><td width="200">66</td><td width="200">1969-10-2</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1967-12-13</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">223</td><td width="200">1967-7-3</td></tr>
<tr><td width="200">BUN</td><td width="200">16</td><td width="200">1967-12-13</td></tr>
<tr><td width="200">HCT</td><td width="200">45</td><td width="200">1967-8-26</td></tr>
<tr><td width="200">HGB</td><td width="200">15</td><td width="200">1967-8-26</td></tr>
<tr><td width="200">Sodium</td><td width="200">137</td><td width="200">1967-12-13</td></tr>
<tr><td width="200">Albumen</td><td width="200">4</td><td width="200">1967-12-13</td></tr>
<tr><td width="200">Creatinine</td><td width="200">1.0</td><td width="200">1967-12-13</td></tr>
<tr><td width="200">Pulse</td><td width="200">81</td><td width="200">1969-10-2</td></tr>
<tr><td width="200">PLT</td><td width="200">248</td><td width="200">1967-7-3</td></tr>
<tr><td width="200">WBC</td><td width="200">14</td><td width="200">1967-7-3</td></tr>
<tr><td width="200">eGFR</td><td width="200">59</td><td width="200">1967-12-13</td></tr>
<tr><td width="200">SGPT</td><td width="200">33</td><td width="200">1967-12-13</td></tr>
<tr><td width="200">target_HBA1c</td><td width="200">7.0</td><td width="200">1969-3-22</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1969-10-2</td></tr>
<tr><td width="200">Atrial_Fibrillation</td><td width="200"></td><td width="200">1969-10-2</td></tr>
<tr><td width="200">DM-Type2</td><td width="200"></td><td width="200">1969-3-22</td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
</table>
<p><b>Medications:</b> spironolactone(25.0) digoxin(0.125) carvedilol(6.25) furosemide(20.0) pravastatin(0.0) enalapril(10.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of heart failure]()</td></tr>
<tr><td width="200">Dyslipidemia Lab criteria</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab criteria[HDL_Cholesterol(33.0/1967-7-3)]()</td></tr>
<tr><td width="200">Heart Failure and BP not controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure[presence of heart failure && BP not adequately controlled based on most recent BPTreatment_Diastolic_BP(90/null)]()</td></tr>
<tr><td width="200">Presence of K sparing diuretics</td>
<td width="200"></td>
<td width="200"> K sparing diuretics[presence of K sparing diuretics]()</td></tr>
<tr><td width="200">Diabetes WITHOUT proteinuria/renal manifestations</td>
<td width="200"></td>
<td width="200"> Diabetes[presence of diabetes mellitus && Absence of diabetic with renal manifestations && Absence of diabetic nephropathy && Absence of diabetic nephrosis && Proteinuria equals trace or above && Absence of ARB]()</td></tr>
<tr><td width="200">DM and BP not controlled</td>
<td width="200"></td>
<td width="200"> Diabetes[presence of DM && BP not adequately controlled based on most recent BPTreatment_Diastolic_BP(90/null)]()</td></tr>
<tr><td width="200">DM BP not controlled  >=1 drug</td>
<td width="200"></td>
<td width="200"> Diabetes[BP not adequately controlled based on most recent BPTreatment_Diastolic_BP(90/null) && presence of diabetes mellitus && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Sex(Female) && Age(69.0/1970-1-1)]()</td></tr>
<tr><td width="200">Dyslipidemia Lab or ICD9</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab or ICD9[presence of dyslipidemia lab criteria]()</td></tr>
<tr><td width="200">CKD by eGFR</td>
<td width="200"></td>
<td width="200"> CKD by eGFR[eGFR(59.0/1967-12-13)]()</td></tr>
<tr><td width="200">CKD by eGFR or ICD9 codes</td>
<td width="200"></td>
<td width="200"> CKD[eGFR(59.0/1967-12-13)]()</td></tr>
<tr><td width="200">On meds & Presence of strong contraindication to HCTZ or using bad drug partner</td>
<td width="200"></td>
<td width="200"> Hypertension[taking furosemide && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">active prescription for furosemide</td>
<td width="200"></td>
<td width="200"> active prescription for furosemide[taking furosemide]()</td></tr>
<tr><td width="200">Age > 65</td>
<td width="200"></td>
<td width="200"> age > 65 years[Age(69.0/1970-1-1)]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">Active prescription for ACE and aldosterone antagonists</td>
<td width="200"></td>
<td width="200"> Active prescription for ACE and aldosterone antagonists[ACE I being used && presence of aldosterone antagonist]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1969-10-02</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1969-10-02</td>
<td width="200"> Atrial_Fibrillation()</td></tr>
<tr><td width="200">Endocrine_Diseases</td>
<td width="200">1969-03-22</td>
<td width="200"> DM-Type2()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> LDL< 100 mg/dL(CHD Risk Equivalent)
<p><b>Reached goal?</b> failed(LDL_Cholesterol(173.0/1967-7-3))
<p>
<b>Goal:</b> SBP < 140 and DBP < 80(presence of diabetes mellitus)
<p><b>Reached goal?</b> failed(Treatment_Diastolic_BP(90/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Class II a</b>
<ul>
<li>It is reasonable to treat patients with atrial fibrillation and HF with a strategy to maintain sinus rhythm or with a strategy to control ventricular rate alone. (Level of Evidence: A)
<li>Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)
</ul>
<li><b>Class I</b>
<ul>
<li>Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
</ul>
<li><b>Class III</b>
<ul>
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage C HF</b><br>
<ul>
</ul>
<li><b> </b><br>
<ul>
<li><b>General Recommendations <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HF ICD9 code OR( signs and structural abnormality)</i> evaluate to <b> true</b> because <i>Presence of HF</i>)])
Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
It is reasonable to treat patients with atrial fibrillation and HF with a strategy to maintain sinus rhythm or with a strategy to control ventricular rate alone. (Level of Evidence: A)
Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)

<li><b>Referrals <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])
Class I
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>hydralazine and nitrates<ul><li>preference: neutral<li>No comment</ul><li>aldosterone antagonist<ul><li>Already being used<li>preference: ruled out</ul><li>Beta blocker for stage C heart failure(Bisoprolol, Sustained release metoprolol succinate, Carvedilol)<ul><li>Already being used<li>preference: ruled out</ul><li>Beta blocker Stage C with MI(Carvedilol)<ul><li>Already being used<li>preference: ruled out</ul></ul><b>Considerations for adding drug: </b><ul><li>Beta Blocker Stage B no MI<ul><li>preference: neutral<li>No comment</ul><li>ARB<ul><li>Relative contraindications:  Active prescription for ACE and aldosterone antagonists(Active prescription for ACE and aldosterone antagonists[ACE I being used && presence of aldosterone antagonist]) <li>preference: neutral</ul><li>Ace_Inhibitor(Enalapril)<ul><li>Already being used<li>preference: ruled out</ul><li>digoxin<ul><li>Already being used<li>preference: ruled out</ul><li>NDHP CCB<ul><li>Contraindications:  Heart_Failure(Heart_Failure) <li>preference: ruled out</ul><li>Beta blocker stage B post MI(atenolol)<ul><li>Already being used<li>preference: ruled out</ul></ul></body></html>